Velarion Records
Free. Unsubscribe any time.

Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc. filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 21 transactions and 269,340 shares. 21 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Definium Therapeutics, Inc. 21

Adoption dates in Definium Therapeutics, Inc. 6

Results prints in Definium Therapeutics, Inc. 9

Trades before a print in Definium Therapeutics, Inc. 0

Interval to Definium Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Definium Therapeutics, Inc. states

Filing text: “10b5-1 plan adopted on May 29, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.